$8.19
2.50% day before yesterday
NYSE, Aug 22, 10:00 pm CET
ISIN
US29332G1022
Symbol
EHAB

Enhabit Stock price

$8.19
+1.43 21.15% 1M
+0.12 1.49% 6M
+0.38 4.87% YTD
+0.17 2.12% 1Y
-7.22 46.85% 3Y
-16.81 67.24% 5Y
-16.81 67.24% 10Y
-16.81 67.24% 20Y
NYSE, Closing price Fri, Aug 22 2025
+0.20 2.50%

Key metrics

Basic
Market capitalization
$415.2m
Enterprise Value
$857.4m
Net debt
$442.2m
Cash
$37.1m
Shares outstanding
50.6m
Valuation (TTM | estimate)
P/E
negative | 18.3
P/S
0.4 | 0.4
EV/Sales
0.8 | 0.8
EV/FCF
17.4
P/B
0.8
Financial Health
Equity Ratio
42.7%
Return on Equity
-29.8%
ROCE
-9.7%
ROIC
-9.7%
Debt/Equity
0.9
Financials (TTM | estimate)
Revenue
$1.0b | $1.1b
EBITDA
$-78.5m | $106.7m
EBIT
$-106.6m | $74.5m
Net Income
$-133.2m | $22.6m
Free Cash Flow
$49.3m
Growth (TTM | estimate)
Revenue
-0.4% | 4.7%
EBITDA
-216.1% | 36.6%
EBIT
-389.7% | 59.8%
Net Income
-1,413.6% | 114.5%
Free Cash Flow
55.0%
Margin (TTM | estimate)
Gross
48.9%
EBITDA
-7.6% | 9.9%
EBIT
-10.3%
Net
-12.8% | 2.1%
Free Cash Flow
4.8%
More
EPS
$-2.6
FCF per Share
$1.0
Short interest
3.1%
Employees
11k
Rev per Employee
$100.0k
Show more

Is Enhabit a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Enhabit Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Enhabit forecast:

6x Buy
55%
5x Hold
45%

Analyst Opinions

11 Analysts have issued a Enhabit forecast:

Buy
55%
Hold
45%

Financial data from Enhabit

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1,038 1,038
0% 0%
100%
- Direct Costs 531 531
1% 1%
51%
507 507
0% 0%
49%
- Selling and Administrative Expenses 424 424
4% 4%
41%
- Research and Development Expense - -
-
-
-79 -79
216% 216%
-8%
- Depreciation and Amortization 28 28
9% 9%
3%
EBIT (Operating Income) EBIT -107 -107
390% 390%
-10%
Net Profit -133 -133
1,414% 1,414%
-13%

In millions USD.

Don't miss a Thing! We will send you all news about Enhabit directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Enhabit Stock News

Neutral
Seeking Alpha
16 days ago
Enhabit, Inc. (NYSE:EHAB ) Q2 2025 Earnings Conference Call August 7, 2025 10:00 AM ET Company Participants Barbara Ann Jacobsmeyer - President, CEO & Director Bob Okunski - Corporate Participant Ryan T. Solomon - Chief Financial Officer Conference Call Participants Albert J.
Positive
The Motley Fool
17 days ago
Enhabit (EHAB) Q2 EPS Jumps 86%
Neutral
Business Wire
18 days ago
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced that Barb Jacobsmeyer, president and CEO, and a member of the board of directors, intends to step down from these roles in July 2026, or upon the appointment of a successor. The company has initiated a leadership succession plan with Jacobsmeyer's full support to ensure a smooth tran...
More Enhabit News

Company Profile

Enhabit, Inc. functions as an investment holding company. It operates under the Home Health and Hospice segments. The Home Health segment provides home health services via home nursing services to adult patients in need of care. The Hospice segment offers hospice agencies. The company was founded in 2014 and is headquartered in Dallas, TX.

Head office United States
CEO Barbara Jacobsmeyer
Employees 10,700
Founded 2014
Website www.ehab.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today